Requirement for Arf6 in breast cancer invasive activities. - Wikidata - wikimedia - TriplyDB

Requirement for Arf6 in breast cancer invasive activities.

Requirement for Arf6 in breast cancer invasive activities.

http://www.wikidata.org/entity/Q33696335

about

Weighted change-point method for detecting differential gene expression in breast cancer microarray data CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery The TBC (Tre-2/Bub2/Cdc16) domain protein TRE17 regulates plasma membrane-endosomal trafficking through activation of Arf6.ASAP3 is a focal adhesion-associated Arf GAP that functions in cell migration and invasion Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis RNA-binding IMPs promote cell adhesion and invadopodia formation.Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion.ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor Beta2-adaptin binds actopaxin and regulates cell spreading, migration and matrix degradation Arf1 and Arf6 promote ventral actin structures formed by acute activation of protein kinase C and Src Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?Wnt Signaling in Cell Motility and Invasion: Drawing Parallels between Development and Cancer High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients The scaffolding protein GRASP/Tamalin directly binds to Dock180 as well as to cytohesins facilitating GTPase crosstalk in epithelial cell migration.Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation.Ral-regulated interaction between Sec5 and paxillin targets Exocyst to focal complexes during cell migration.A fluorescence resonance energy transfer activation sensor for Arf6 Endogenous ARF6 interacts with Rac1 upon angiotensin II stimulation to regulate membrane ruffling and cell migration.ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway ARL4D recruits cytohesin-2/ARNO to modulate actin remodeling Arf6 regulation of Gyrating-clathrin Microtubule-dependent endosomal sorting of clathrin-independent cargo by Hook1.ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk.Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer.Unregulated ARF6 activation in epithelial cysts generates hyperactive signaling endosomes and disrupts morphogenesis.GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.The oncogenic TBC domain protein USP6/TRE17 regulates cell migration and cytokinesis.Down-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion.ADP-ribosylation factor 6 expression and activation are reduced in myometrium in complicated pregnancies.IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer.Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.Melanoma risk loci as determinants of melanoma recurrence and survival Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma.Critical role of transient activity of MT1-MMP for ECM degradation in invadopodia Podosomes and Invadopodia: Related structures with Common Protein Components that May Promote Breast Cancer Cellular Invasion.Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapy

P2860

Q21134908-91B1CD90-290D-4F19-B276-4603C836A7BD Q24294662-39BF3FBC-3587-4749-B7C1-2E30040FCE8D Q24309600-679637FB-7DB2-43E8-9F73-52132983B3EB Q24318780-A6A1B647-0F38-49E1-A44F-A672C99F97DB Q24320165-35DF7ABA-6BDB-4C59-A806-FA256EF8C0C9 Q24542808-AF90E7AF-2C11-4728-9C28-CE662784B729 Q24555819-2BD0B38C-703B-4B2E-B528-B73280FCEDF1 Q27308938-7B324CAB-CE7D-4EC2-9B24-CF8714DDB931 Q27309213-5D9D3FF2-C54D-48BF-A4D7-0B968951A2BF Q27310686-3EE32E8E-48F5-42A7-BDFE-94154AE09176 Q27316558-2A3FAB40-F6B2-4182-85EE-48D4E9B5C5EC Q27337663-B0B25C78-A966-47B9-B36D-1E1E87A06B18 Q27690752-3BB14BDA-D40A-4D8D-9B1F-434B921B5923 Q28077330-304732B6-075A-4AA4-86C0-F679BAD76E47 Q28658539-86B481B1-4763-489B-82F1-1DCBF1ADF85D Q30009916-AB5DE135-1375-444F-8902-359B237BDCB0 Q30157203-7F3DF34A-ECC2-4762-9DA5-1C93B44ED5F7 Q30393951-72A04AA3-5ABA-43F9-9565-7C95BCF6F221 Q30440034-3E5C9199-4149-4806-8788-6A5C61B1588A Q30445163-0A95F0F1-4454-4C70-99CB-24C6EC584DEF Q30448719-4C8CA374-94F1-44B5-A4AF-BE6A39EB8555 Q30480315-143D6323-ED82-4879-93EA-7BA424850BB2 Q30532602-2CC4EA03-FAB3-4949-BD79-6CB09A792EFA Q30538936-3767E0E0-E3A0-4FB4-AE76-CDDC975B27CA Q30560783-D1C532F9-4BE3-4B09-A9B2-0D8469965BDC Q33565679-9443C538-E643-422D-BCCF-3DA574F9714E Q33892896-7CEF85E2-8C5E-41C9-B845-830B047D2B56 Q33948593-6D8649A4-C118-4543-80CB-DFCD58C7CFA6 Q33999514-4A34F393-E1BA-458D-95EB-2FDB6DC4D28F Q34038203-CEDD0CB6-B9F0-4376-B367-31F050B0F237 Q34242097-877385F8-56F9-46B8-AE91-0926587C53D2 Q34291356-806C54F2-F7D7-41D7-9084-9D753A32B6A8 Q34292734-2B881B1E-1CAA-4FDB-BD31-67BA1EFB80F7 Q34334410-D16C90C0-A4E6-4A44-AFB9-EE5F4F4F9A96 Q34375074-E57B601A-D9EB-44E7-BAB8-E6C52F9450B0 Q34493237-DE508ABA-8596-413A-A19F-E5DDFE0ADC10 Q34732908-D431DCDD-BA7B-4273-8A55-88D99CD2CD6E Q34758204-10595C8D-9220-416B-B0FC-D39AD83D6B40 Q34897371-3BD3C48C-7104-4600-9A04-35079255127F Q35014893-838E6324-CBAC-416F-9E72-EE4C2D299F3C

P2860

Requirement for Arf6 in breast cancer invasive activities.

http://www.wikidata.org/entity/Q33696335

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Requirement for Arf6 in breast cancer invasive activities.

@ast

Requirement for Arf6 in breast cancer invasive activities.

@en

type

label

Requirement for Arf6 in breast cancer invasive activities.

@ast

Requirement for Arf6 in breast cancer invasive activities.

@en

prefLabel

Requirement for Arf6 in breast cancer invasive activities.

@ast

Requirement for Arf6 in breast cancer invasive activities.

@en

P1433

Q33696335-528E5402-772F-42F9-BA7E-A65CEE378B50

P1476

Q33696335-CC2FDFE8-EA86-4098-BFD0-25FE97B45A19

P2093

Q33696335-20A27838-8D9C-41AD-9781-DC9DF379A8CA

Q33696335-247C4237-4338-4344-AF12-5CA9A8BEB867

Q33696335-32DE38A5-38EC-4B67-8A48-AD2181F862D5

Q33696335-339666FE-3257-497B-A555-68278B64C08D

Q33696335-3BC08930-26F2-435D-B46C-E54A6DA3B8E7

Q33696335-4881B67A-FD3B-478A-AA1F-17CF2B9E9A8B

Q33696335-626033DF-1004-4B6D-873D-1FB24EC21F55

P2860

Q33696335-12A21D6A-DD28-4CAC-B11E-D6CE7C816C0C

Q33696335-1ED070A9-2B0D-44D4-8B12-C02136959A53

Q33696335-257053D4-9E14-40A3-9D5E-B1F5603DC6F8

Q33696335-38025DC5-D92F-4F93-BFA4-11EBECF69F2F

Q33696335-3F910FF5-ADA2-4B86-919C-3B95F8C288C0

Q33696335-4514B755-8CEC-4AFE-BA54-D61878BCDDF9

Q33696335-54BC76E1-9966-4C24-A074-79DC89D59C3B

Q33696335-55FDED8E-3EE7-428B-BBD4-ED923DEBAF25

Q33696335-56AA444E-6843-411B-9A39-C8B8336A7252

Q33696335-6E26AA0E-A038-4396-9962-36D02E44F85A

P304

Q33696335-EB7E1E2A-EBB0-4055-9327-B0B22A4B9D3D

P31

Q33696335-3FF3A2C3-A705-4529-8498-704DDE9F4CA6

P356

Q33696335-037D356A-0047-4639-ABCD-7D02F6D3D589

P407

Q33696335-D59BE770-BD2B-412A-AF46-54EE4CD16054

P433

Q33696335-4C3C1D78-D030-4B75-8536-D74E9C08522B

P478

Q33696335-AA1A5F90-7D37-4D33-9644-E552273CD4C2

P577

Q33696335-626ED5D9-D5BB-4BA5-A49B-54B7BBB5774E

P5875

Q33696335-0D68752D-6C2B-4D16-8E32-4436F0A9A2EB

P698

Q33696335-DC815BBD-F277-40E6-800D-7A183FE2926F

P932

Q33696335-9E827E02-F20E-45E1-9F4B-FC0F6BA47F2B

P356

PNAS.0401753101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Requirement for Arf6 in breast cancer invasive activities.

@en

P2093

Ari Hashimoto

http://www.w3.org/2001/XMLSchema#string

Atsuko Yamada

http://www.w3.org/2001/XMLSchema#string

Hisataka Sabe

http://www.w3.org/2001/XMLSchema#string

Michinari Hamaguchi

http://www.w3.org/2001/XMLSchema#string

Miwa Tanaka

http://www.w3.org/2001/XMLSchema#string

Shigeru Hashimoto

http://www.w3.org/2001/XMLSchema#string

Yasuhito Onodera

http://www.w3.org/2001/XMLSchema#string

P2860

Arfaptin 1 inhibits ADP-ribosylation factor-dependent matrix metalloproteinase-9 secretion induced by phorbol ester in HT 1080 fibrosarcoma cells

A new paxillin-binding protein, PAG3/Papalpha/KIAA0400, bearing an ADP-ribosylation factor GTPase-activating protein activity, is involved in paxillin recruitment to focal adhesions and cell migration

PAG3/Papalpha/KIAA0400, a GTPase-activating protein for ADP-ribosylation factor (ARF), regulates ARF6 in Fcgamma receptor-mediated phagocytosis of macrophages

Gene expression profiling predicts clinical outcome of breast cancer

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Cytohesins and centaurins: mediators of PI 3-kinase-regulated Arf signaling

Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

Tumour-cell invasion and migration: diversity and escape mechanisms

P304

6647-6652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0401753101

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8615042

http://www.w3.org/2001/XMLSchema#string

P698

15087504

http://www.w3.org/2001/XMLSchema#string

P932

404099

http://www.w3.org/2001/XMLSchema#string